A single point mutation within the coding sequence of cholera toxin B subunit will increase its expression yield

Iranian Biomedical Journal

Volumn 18, Issue 3, 2014, Pages 130-135

  Bakhshi, Bita ^a   Boustanshenas, Mina ^b   Ghorbani, Masoud ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Cholera toxin B subunit (CTB); Escherichia coli; Point mutation; Protein expression

Indexed keywords

CHOLERA TOXIN B SUBUNIT; CHOLERA TOXIN; DNA; MUTANT PROTEIN; RECOMBINANT PROTEIN;

AMINO ACID SUBSTITUTION; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; CTXB GENE; ESCHERICHIA COLI; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; MOLECULAR CLONING; MUTAGENESIS; NONHUMAN; POINT MUTATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; VIBRIO CHOLERAE; WESTERN BLOTTING; AGAR GEL ELECTROPHORESIS; AMINO ACID SEQUENCE; GENETICS; METABOLISM; OPEN READING FRAME;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CHOLERA TOXIN; CLONING, MOLECULAR; DNA; ELECTROPHORESIS, AGAR GEL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; MUTANT PROTEINS; OPEN READING FRAMES; POINT MUTATION; POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS;

EID: 84900832720     PISSN: 1028852X     EISSN: None     Source Type: Journal    
DOI: 10.6091/ibj.1165.2014     Document Type: Article

References (35)

1. 1 in Bangladesh. Lancet. 1993 Mar; 341(8846):704.
2. Faruque SM, Albert MJ, Mekalanons JJ. Epidemiology, genetics, and ecology of toxigenic Vibrio cholerae. Microbiol Mol Biol Rev. 1998 Dec; 62(4):1301-14.
3. Kanungo S, Sah BK, Lopez AL, Sung JS, Paisley AM, Sur D. Cholera in India: an analysis of reports, 1997-2006. Bull World Health Organ. 2010 Mar; 88(3):185-91.
4. Bakhshi B, Pourshafie MR. Assessing clonality of Vibrio cholerae strains isolated during four consecutive years (2004-2007) in Iran. Scand J Infect Dis. 2009; 41(4):256-62.
5. Bakhshi B, Pourshafie MR, Navabakbar F, Tavakoli A, Shahcheraghi F, Salehi M, et al. Comparison of distribution of virulence determinants in clinical and environmental isolates of Vibrio cholerae. Iran Biomed J. 2008 Jul; 12(3):159-65.
6. Thungapathra M, Sharma C, Gupta N, Ghosh RK, Mukhopadhyay A, Koley H, et al. Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model. Immunol Lett. 1999 Jun; 68(2-3):219-27.
7. Rudin A, Riise GC, Holmgren J. Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect Immun. 1999 Jun; 67(6):2884-90.
8. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature. 1981 Jul; 292(5822): 413-17.
9. Holmgren J, Fredman P, Lindblad M, Svennerholm AM, Svennerholm L. Rabbit intestinal glycoprotein receptor for Escherichia coli heat-labile enterotoxin lacking affinity for cholera toxin. Infect Immun. 1982 Nov; 38(2):424-33.
10. de Aizpurua HJ, Russell-Jones GJ. Oral vaccination. Identification of classes of proteins that provoke an immune response upon oral feeding. J Exp Med. 1988 Feb; 167(2):440-51.
11. Glass RI, Holmgren J, Khan MR, Hossain KM, Huq MI, Greenough WB. A randomized, controlled trial of the toxin-blocking effects of B subunit in family members of patients with cholera. J Infect Dis. 1984 Apr; 149(4):495-500.
12. Li TK, Fox BS. Cholera toxin B subunit binding to an antigen presenting cell directly co-stimulates cytokine Expression from a T cell clone. Int Immunol. 1996 Dec; 8(12):1849-56.
13. Gong Z, Long X, Pan L, Le Y, Liu Q, Wang S, et al. Cloning, expression, purification and characterization of the cholera toxin B subunit and triple glutamic acid decarboxylase epitopes fusion protein in Escherichia coli. Protein Expr Purif. 2009 Aug; 66(2):191-97.
14. Harakuni T, Sugawa H, Komesu A, Tadano M, Arakawa T. Heteropentameric cholera toxin B subunit chimeric molecules genetically fused to a vaccine antigen induces systemic and mucosal immune responses: a potential new strategy to target recombinant vaccine antigens to mucosal immune systems. Infect Immun. 2005 Sep; 73(9):5654-65.
15. Miyata T, Harakuni T, Tsuboi T, Sattabongkot J, Kohama H, Tachibana M, et al. Plasmodium vivax ookinete surface protein Pvs25 linked to cholera toxin B subunit induces potent transmission-blocking immunity by intranasal as well as subcutaneous immunization. Infect Immun. 2010 Sep; 78(9):3773-3782.
16. Kenner JR, Coster TS, Taylor DN, Trofa AF, Barrera-Oro M, Hyman T, Adams JM, Beattie DT, Killeen KP, Spriggs DR. Peru-15, an improved live attenuated oral vaccine candidate for Vibrio cholerae O1. J Infect Dis. 1995 Oct; 172(4):1126-29.
17. Taylor DN, Killeen KP, Hack DC, Kenner JR, Coster TS, Beattie DT, et al. Development of a live, oral, attenuated vaccine against El Tor cholera. J Infect Dis. 1994 Dec; 170(6):1518-23.
18. Bergquist C, Johansson EL, Lagergard T, Holmgren J, Rudin A. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina. Infect Immun. 1997 Jul; 65(7): 2676-84.
19. Arêas APM, Oliveira MLS, Ramos CRR, Sbrogio-Almeida ME, Raw I, Ho PL. Synthesis of cholera toxin B subunit gene: cloning and expression of a functional 6XHis-tagged protein in Escherichia coli. Protein Expr Purif. 2002 Aug; 25(3):481-487.
20. Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, et al. A cholera toxoid-insulin conjugate as an oral vaccine against 486 spontaneous autoimmune diabetes. Proc Natl Acad Sci USA. 1997 Apr; 94(9): 4610-14.
21. Fontana MR, Monaci E, Yanqing L, Guoming Q, Duan G, Rappuoli R, et al. IEM101, a naturally attenuated Vibrio cholerae strain, as carrier for genetically detoxified derivatives of cholera toxin. Vaccine. 2000 Aug; 19(1):75-85.
22. Ryan ET, Calderwood SB. Cholera vaccines. Clin Infect Dis. 2000 Aug; 31(2):561-5.
23. Rijpkema SGT, Bik EM, Jansen WH, Gielen H, Versluis LF, Stouthamer AH, et al. Construction and analysis of a Vibrio cholerae delta-aminolevulinic acid auxotroph which confers protective immunity in a rabbit model. Infect Immun. 1992 Jun; 60(6):2188-93.]
24. L'Hoir C, Renard A, Martial JA. Expression in Escherichia coli of two mutated encoding the cholera toxin B subunit. Gene. 1990 Apr; 89(1):47-52.
25. Slos P, Dutot P, Reymund J, Kleinpeter P, Prozzi D, Kieny MP, et al. Production of cholera toxin B subunit in Lactobacillus. FEMS Microbiol Lett. 1998 Dec; 169(1):29-36.
26. Goto N, Maeyama J, Yasuda Y, Isaka M, Matano K, Kozuka S, et al. Safety evaluation of recombinant cholera toxin B subunit produced by Bacillus brevis as a mucosal adjuvant. Vaccine. 2000 Apr; 18(20):2164-71.
27. Arzanlou M, Rezaee A, Shahrokhi N, Hossini A, Yasuda Y, Tochikubo K, et al. Expression of cholera toxin B subunit in Saccharomyces cerevisiae. Ann Microbiol. 2005 55(2):145-50.
28. Shamini G, Ravichandran M, Sinnott JT, Somboonwit C, Sidhu HS, Shapshak P, et al. Structural inferences for Cholera toxin mutations in Vibrio cholerae. Bioinformation. 2011 Mar; 6(1):1-9.
29. Ansaruzzaman M, Bhuiyan NA, Nair BG, Sack DA, Lucas M, Deen JL, et al. Cholera in Mozambique, variant of Vibrio cholera. Emerg Infect Dis. 2004 Nov;10(11):2057-9.
30. Kumar P, Jain M, Goel AK, Bhadauria S, Sharma SK, Kamboj DV, et al. A large cholera outbreak due to a new cholera toxin variant of the Vibrio cholerae O1 El Tor biotype in Orissa, Eastern India. J Med Microbiol. 2009 Feb; 58(2):234-8.
31. Merritt EA, Sarfaty S, Jobling MG, Chang T, Holmes RK, Hirst TR, et al. Structural studies of receptor binding by cholera toxin mutants. Protein Sci. 1997 Jul; 6(7):1516-28.
32. Silva A, Fando R, Benitez JA. Overexpression of a mutant B subunit in toxigenic Vibrio cholerae diminishes production of active cholera toxin in vivo. Curr Microbiol. 1998 Oct; 37(4):231-35.
33. Aman AT, Fraser S, Merritt EA, Rodigherio C, Kenny M, Ahn M, et al. A mutant cholera toxin B subunit that binds GM1-ganglioside but lacks immunomodulatory or toxic activity. Proc Natl Acad Sci USA. 2001 Jul; 98(15):8536-41.
34. Boustanshenas M, Bakhshi B, Ghorbani M, Norouzian D. Comparison of two recombinant systems for expression of cholera toxin B subunit from Vibrio cholerae. Indian J Med Microbiol. 2012; 31(1):10-14.
35. Mina Boustanshenas, Bita Bakhshi, Masoud Ghorbani. Investigation of immunological responses against a native recombinant CTB-whole cell Vibrio cholerae vaccine in a rabbit model. J Appl Microbiol. 2013 Feb; 114(2):509-15.